PATIENT STORIES

Coronary Microvascular Dysfunction
In Their Own Words

For many patients suffering from Coronary Microvascular Dysfunction (CMD), seeking a definitive diagnosis typically means years of burdensome, costly, and inconclusive testing.

4 min

Cindy's Story

“CMD had a significant impact on my day-to-day life and what I was able to do.”
3 min

Jill's Story

“I would really like [my experience] to not be what other people have to do to get the same diagnosis.”
how magnetocardiography can help

Patient & Physician Testimonials

Read what patients and physicians alike think about the potential CardioFlux MCG has to change the standard of care in diagnosing CMD.

Amber

CMD Patient

"It took a total of 90 seconds, in and out, and I was done. And I was able to go back to work the same day."

Cindy

CMD Patient

"This is easier and faster and non invasive. It was no more than five minutes. If it can be a diagnostic tool, it would be phenomenal."

Dr. Odayme Quesada

Medical Director, The Christ Hospital Women's Heart Center

“If MCG works as intended and can lead to far earlier management of CMD, it’s exactly these patients who stand to benefit the most.”

Dr. Robert Takla

Genetesis Chief Medical Officer

"In that same 90 second test that we're looking for evidence of functional ischemia at a coronary artery level, we're able to detect microvascular dysfunction with that same testing."

Peeyush Shrivastava

Genetesis CEO

"Microvascular disease...today it's a disease of exclusion. Perhaps it's your micro vessels. Let's make that perhaps something definitive."

Jill

CMD Patient

"I'm worried one day my daughter might have the same issue and I'm really looking forward to CardioFlux being more available, a better option, especially down the road for my daughter or any other women."
THE ProMISE OF MCG

Dr. Quesada: CMD & CardioFlux

Dr. Odayme Quesada, MD, Medical Director of the Women's Heart Center at The Christ Hospital Health Network talks about the difficulties of diagnosing Coronary Microvascular Dysfunction and the role CardioFlux could play in addressing an unmet need in this patient population.

90 seconds to scan

Completely non-invasive

Zero radiation